XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Collaboration Agreements - Additional Information (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Aug. 31, 2020
USD ($)
Program
Oct. 31, 2018
Program
Mar. 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
Sep. 30, 2020
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2022
USD ($)
Sep. 30, 2021
USD ($)
Dec. 31, 2020
USD ($)
2018 Gilead Agreement [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Research term   3 years              
Number of licensed product | Program   5              
Non-refundable upfront payment received     $ 50,000,000.0     $ 50,000,000.0      
Amended Gilead Agreement [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Research term 7 years                
Number of licensed product | Program 15                
Non-refundable upfront payment received     $ 125,000,000.0            
Milestone payments receivable $ 410,000,000.0                
Temporary equity, par value 125,000,000.0                
Revenue recognized, cumulative catch-up adjustment         $ (11,300,000)        
Research extension fee               $ 12,000,000.0 $ 12,000,000.0
Amended Gilead Agreement [Member] | Minimum [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Ownership percentage in common stock     10.00%            
Amended Gilead Agreement [Member] | Series B-1 Preferred Stock [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Temporary equity, par value $ 20,000,000.0                
Gilead Agreement [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Transaction price allocated to performance obligation     $ 199,000,000.0            
Cummulative research extension fee     24,000,000.0            
Short-term deferred revenue     34,000,000.0       $ 31,800,000    
Long-term deferred revenue     84,100,000       $ 92,100,000    
Collaboration Revenue [Member] | Gilead Agreement [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Contract with customer liability, revenue recognized     $ 5,800,000 $ 5,800,000